These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4302260)

  • 1. Serotonin infusion in rats with experimental renovascular hypertension.
    Fisher ER; Keverline PO
    J Pharm Sci; 1968 Nov; 57(11):1966-8. PubMed ID: 4302260
    [No Abstract]   [Full Text] [Related]  

  • 2. Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension.
    Donker AJ; Leenen FH
    Lancet; 1974 Dec; 2(7896):1535-7. PubMed ID: 4140980
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of the antihypertensive effect of 1-Sar-8-Ala-angiotensin II during the acute phase of experimental renal hypertension.
    Pals DT; Fulton RW
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):20-30. PubMed ID: 4355711
    [No Abstract]   [Full Text] [Related]  

  • 4. Pressor responsiveness to renin and angiotensin in renal hypertensive rats.
    Aoki K; Masson GM
    Nephron; 1969; 6(4):484-97. PubMed ID: 4310884
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Saluretic action of angiotensin II in essential and renovascular hypertension].
    Zeneroli ML
    Endocrinol Sci Cost; 1970 Jul; 31(3):195-200. PubMed ID: 4323807
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of an angiotension II analogue].
    Ogiwara T; Yamamoto T; Kumahara Y; Sakakibara S
    Nihon Rinsho; 1973 Dec; 31(12):3552-5. PubMed ID: 4364961
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH
    Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
    [No Abstract]   [Full Text] [Related]  

  • 9. Renovascular hypertension: diagnostic problems and therapeutic implications.
    Izzo JL
    JAMA; 1983 Jan; 249(3):398-9. PubMed ID: 6848833
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiotensin II analogue and essential hypertension].
    Kono T; Ikeda F; Oseko F; Imura H; Shimbo S; Endo J
    Nihon Rinsho; 1979 Oct; 37(10):3503-10. PubMed ID: 392137
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical applications of synthetic angiotensin II analogue.
    Ogihara T; Yamamoto T; Kumahara Y
    Jpn Circ J; 1974 Nov; 38(11):997-1003. PubMed ID: 4373592
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Angiotensin blockade.
    Ogihara T; Yamamoto T; Kumahara Y
    Lancet; 1974 Feb; 1(7850):219. PubMed ID: 4129905
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma renin and the antihypertensive effect of 1-Sar-8-Ala-angiotensin II.
    Pals DT; Masucci FD
    Eur J Pharmacol; 1973 Jul; 23(1):115-9. PubMed ID: 4354806
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive value of angiotensin II antagonists in renovascular hypertension.
    Fouad FM; Gifford RW; Fighali S; Mujais SK; Novick AC; Bravo EL; Tarazi RC
    JAMA; 1983 Jan; 249(3):368-73. PubMed ID: 6336802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Saralasin for renovascular or essential hypertension (author's transl)].
    Arlart I; Rosenthal J
    Dtsch Med Wochenschr; 1978 Nov; 103(45):1790-6. PubMed ID: 710289
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of aminopeptidase on experimental renal hypertension in rats].
    Klaus D; Daum A
    Klin Wochenschr; 1966 Aug; 44(15):903-4. PubMed ID: 4296034
    [No Abstract]   [Full Text] [Related]  

  • 20. Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.
    Rajapakse NW; De Miguel C; Das S; Mattson DL
    Hypertension; 2008 Dec; 52(6):1084-90. PubMed ID: 18981330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.